An animal model has been found to correlate closely with human disease from Pneumocystis carinii. Rats maintained for 2 to 3 months on corticosteroids and antibiotics will regularly acquire extensive P. carinii pneumonitis. In 1974, this animal model was used to determine that trimethoprim-sulfamethoxazole administered daily was highly effective in the prevention of the pneumonitis (5) . Subsequently, clinical studies in cancer patients showed results identical to those in animals (3, 4, 6 At the end of 2 months of immunosuppression, all of the surviving rats were sacrificed by carbon dioxide.
Autopsies were done at the time of death. Sections of the right lungs were taken for histopathology. The Formalin-fixed specimens were sectioned for slides and stained with Gomori's methenamine silver nitrate technique. Also, imprints of the cut surface of fresh lung specimens were made on microscope slides and stained with toluidine blue 0. An animal was considered free of P. carinii if no organisms were found on two lung sections or on lung imprint preparations. At least two unequivocal P. carinii cysts were required for an infected animal. However, all infected animals had at least several hundred cysts on a single lung section as well as imprints.
The results are summarized in Table 1 . Two animals in group 1, four in group 2, and two in group 3 died between 6 and 8 weeks of immuno- It has been demonstrated that trimethoprimsulfamethoxazole treatment does not eradicate P. carinii from the host. In a previous study, we found that rats treated continuously for 6 weeks with the drugs and then placed in barrier isolators to prevent acquisition of P. carinii during immunosuppression had exacerbation of latent P. carinii infections in 90% of the animals (1).
Although the incubation period for P. carinii pneumonitis is not well delineated, it is believed to be about 3 to 6 weeks, based on the acquisition of the disease in endemic nurseries and studies in germfiree rats (2) . This rather long incubation period perhaps accounts for the success of the intermittent prophylactic regimen observed in our study. The 3-day courses of trimethoprim-sulfamethoxazole, interrupted at 4-day intervals without the drug, seem adequate to maintain the organism in a latent, subclinical state. Whether variations of this scheme might be equally successful is not known.
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